ADVANCED MALIGNANT PLEURAL MESOTHELIOMA

Clinical trials for ADVANCED MALIGNANT PLEURAL MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED MALIGNANT PLEURAL MESOTHELIOMA trials appear

Sign up with your email to follow new studies for ADVANCED MALIGNANT PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Terminated trial sought new hope for tough cancer

Disease control Terminated

This early-stage study tested whether combining a targeted, high-dose radiation (SBRT) with an immunotherapy drug (pembrolizumab) was safe and effective for patients with advanced, inoperable pleural mesothelioma whose cancer had progressed after initial chemotherapy. The trial w…

Matched conditions: ADVANCED MALIGNANT PLEURAL MESOTHELIOMA

Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

ADVANCED MALIGNANT PLEURAL MESOTHELIOMA

Get alerted when new ADVANCED MALIGNANT PLEURAL MESOTHELIOMA trials appear

Terminated trial sought new hope for tough cancer